Evaluation and Management of Chronic Pulmonary Thromboembolic Disease

References

• . White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 suppl 1):I4–I8
   PubMed Web of Science ®Google Scholar
• . Miniati M, Monti S, Bottai M, . Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 2006;85(5):253–262
   PubMed Web of Science ®Google Scholar
• . Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386–1389
   PubMed Web of Science ®Google Scholar
• . Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133( 6 suppl):454S–545S
   PubMed Web of Science ®Google Scholar
• . Schulman S, Rhedin AS, Lindmarker P, . A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration Of Anticoagulation Trial Study Group. N Engl J Med. 1995;332(25):1661–1665
   PubMed Web of Science ®Google Scholar
• . Kearon C, Ginsberg JS, Anderson DR, ; SOFAST Investigators. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost. 2004;2(5):743–749
   PubMed Web of Science ®Google Scholar
• . Pinede L, Ninet J, Duhaut P, ; Investigators of the “Durée Optimale du Traitement AntiVitamines K” (DOTAVK) Study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation. 2001;103(20):2453–2460
   PubMed Web of Science ®Google Scholar
• . Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ. 2007;334(7595):674
   PubMedGoogle Scholar
• . Klok FA, Zondag W, van Kralingen KW, . Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med. 2010;181(5):501–506
   PubMed Web of Science ®Google Scholar
• . Agnelli G, Prandoni P, Becattini C, ; Warfarin Optimal Duration Italian Trial Investigators. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med. 2003;139(1):19–25
   PubMed Web of Science ®Google Scholar
• . Prandoni P, Noventa F, Ghirarduzzi A, . The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92(2):199–205
   PubMed Web of Science ®Google Scholar
• . Agnelli G, Prandoni P, Santamaria MG, ; Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001;345(3):165–169
   PubMed Web of Science ®Google Scholar
• . Kearon C, Gent M, Hirsh J, . A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340(12): 901–907
   PubMed Web of Science ®Google Scholar
• . Fihn SD, McDonell M, Martin D, . Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med. 1993;118(7):511–520
   PubMed Web of Science ®Google Scholar
• . Palareti G, Leali N, Coccheri S, . Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348(9025):423–428
   PubMed Web of Science ®Google Scholar
• . Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003;139(11):893–900
   PubMed Web of Science ®Google Scholar
• . Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119( 1 suppl): 108S–121S
   PubMed Web of Science ®Google Scholar
• . Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120(11):897–902
   PubMed Web of Science ®Google Scholar
• . Gage BF, Yan Y, Milligan PE, . Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713–719
   PubMed Web of Science ®Google Scholar
• . Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87(2):144–152
   PubMed Web of Science ®Google Scholar
• . Fang MC, Go AS, Chang Y, . Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007;120(8):700–705
   PubMed Web of Science ®Google Scholar
• . Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105(2):91–99
   PubMed Web of Science ®Google Scholar
• . Wells PS, Forgie MA, Simms M, . The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Arch Intern Med. 2003;163(8):917–920
   PubMedGoogle Scholar
• . Palareti G, Cosmi B, Legnani C, ; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355(17):1780–1789
   PubMed Web of Science ®Google Scholar
• . Cosmi B, Legnani C, Tosetto A, ; PROLONG Investigators (on behalf of Italian Federation of Anticoagulation Clinics). Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood. 2010;115(3):481–488
   PubMed Web of Science ®Google Scholar
• . Findik S, Erkan ML, Selçuk MB, Albayrak S, Atici AG, Doru F. Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism. Respiration. 2002;69(5):440–444
   PubMed Web of Science ®Google Scholar
• . Simonneau G, Sors H, Charbonnier B, . A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med. 1997;337(10):663–669
   PubMedGoogle Scholar
• . Büller HR, Davidson BL, Decousus H, ; Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349(18):1695–1702
   PubMed Web of Science ®Google Scholar
• . Beckman JA, Dunn K, Sasahara AA, Goldhaber SZ. Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism. Thromb Haemost. 2003;89(6):953–958
   PubMed Web of Science ®Google Scholar
• . Kucher N, Quiroz R, McKean S, Sasahara AA, Goldhaber SZ. Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med. 2005;10(4):251–256
   PubMed Web of Science ®Google Scholar
• . Iorio A, Guercini F, Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost. 2003;1(9):1906–1913
   PubMed Web of Science ®Google Scholar
• . Meyer G, Marjanovic Z, Valcke J, . Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med. 2002;162(15):1729–1735
   PubMed Web of Science ®Google Scholar
• . Lee AY, Levine MN, Baker RI, ; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349(2):146–153
   PubMed Web of Science ®Google Scholar
• . Hull RD, Pineo GF, Brant RF, ; LITE Trial Investigators. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med. 2006;119(12):1062–1072
   PubMed Web of Science ®Google Scholar
• . Lee AY, Rickles FR, Julian JA, . Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23(10):2123–2129
   PubMed Web of Science ®Google Scholar
• . Ojeda E, Perez MC, Mataix R, . Skin necrosis with a low molecular weight heparin. Br J Haematol. 1992;82(3):620
   PubMed Web of Science ®Google Scholar
• . Lyman GH, Khorana AA, Falanga A, ; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25(34):5490–5505
   PubMed Web of Science ®Google Scholar
• . Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg. 2008;14(5):274–282
   PubMed Web of Science ®Google Scholar
• . PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416–422
   PubMed Web of Science ®Google Scholar
• . Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology. 2000;216(1):54–66
   PubMed Web of Science ®Google Scholar
• . Shang EK, Nathan DP, Carpenter JP, Fairman RM, Jackson BM. Delayed complications of inferior vena cava filters: case report and literature review. Vasc Endovascular Surg. 2011;45(3):290–294
   PubMed Web of Science ®Google Scholar
• . Nazzal M, Chan E, Nazzal M, . Complications related to inferior vena cava filters: a single-center experience. Ann Vasc Surg. 2010;24(4):480–486
   PubMed Web of Science ®Google Scholar
• . Van Ha TG, Chien AS, Funaki BS, . Use of retrievable compared to permanent inferior vena cava filters: a single-institution experience. Cardiovasc Intervent Radiol. 2008;31(2):308–315
   PubMed Web of Science ®Google Scholar
• . Kim HS, Young MJ, Narayan AK, Hong K, Liddell RP, Streiff MB. A comparison of clinical outcomes with retrievable and permanent inferior vena cava filters. J Vasc Interv Radiol. 2008;19(3):393–399
   PubMed Web of Science ®Google Scholar
• . Mismetti P, Rivron-Guillot K, Quenet S, . A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest. 2007;131(1):223–229
   PubMed Web of Science ®Google Scholar
• . Haddadian B, Shaikh F, Djelmami-Hani M, Shalev Y. Sudden cardiac death caused by migration of a TrapEase inferior vena cava filter: case report and review of the literature. Clin Cardiol. 2008;31(2):84–87
   PubMed Web of Science ®Google Scholar
• . ; British Committee for Standards in Haematology Writing GroupBaglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol. 2006;134(6):590–595
   PubMed Web of Science ®Google Scholar
• . Jaff MR, McMurtry MS, Archer SL, ; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830
   PubMed Web of Science ®Google Scholar
• . Yamagami T, Tanaka O, Yoshimatsu R, Miura H, Nishimura T. Venous thromboembolism after removal of retrievable inferior vena cava filters. Cardiovasc Intervent Radiol. 2010;33(1):74–79
   PubMed Web of Science ®Google Scholar
• . Ko SH, Reynolds BR, Nicholas DH, . Institutional protocol improves retrievable inferior vena cava filter recovery rate. Surgery. 2009;146(4):809–814
   PubMed Web of Science ®Google Scholar
• . Carson JL, Kelley MA, Duff A, . The clinical course of pulmonary embolism. N Engl J Med. 1992;326(19):1240–1245
   PubMed Web of Science ®Google Scholar
• . Nijkeuter M, Söhne M, Tick LW, ; Christopher Study Investigators. The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest. 2007;131(2):517–523
   PubMed Web of Science ®Google Scholar
• . Zondag W, Klok FA, Nijkeuter M, . Comparison of risk profile and clinical outcome of patients after acute pulmonary embolism in university and non-university hospitals. J Thromb Haemost. 2010;8(2):407–409
   PubMed Web of Science ®Google Scholar
• . Bova C, Pesavento R, Marchiori A, ; TELESIO Study Group. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost. 2009;7(6):938–944
   PubMed Web of Science ®Google Scholar
• . Van Rossum AB, Pattynama PM, Tjin A Ton E, Kieft GJ. Spiral CT appearance of resolving clots at 6 week follow-up after acute pulmonary embolism. J Comput Assist Tomogr. 1998;22(3):413–417
   PubMed Web of Science ®Google Scholar
• . Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest. 2006;129(1):192–197
   PubMed Web of Science ®Google Scholar
• . Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761–768
   PubMed Web of Science ®Google Scholar
• . Badesch DB, Champion HC, Sanchez MA, . Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54( 1 suppl):S55–S66
   PubMed Web of Science ®Google Scholar
• . Pengo V, Lensing AW, Prins MH, ; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–2264
   PubMed Web of Science ®Google Scholar
• . Tunariu N, Gibbs SJ, Win Z, . Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680–684
   PubMed Web of Science ®Google Scholar
• . Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71(1):49–54
   PubMed Web of Science ®Google Scholar
• . Kreitner KF, Ley S, Kauczor HU, . Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology. 2004;232(2):535–543
   PubMed Web of Science ®Google Scholar
• . Fedullo P, Kerr KM, Kim NH, Auger WR. Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2011;183(12):1605–1613
   PubMed Web of Science ®Google Scholar
• . Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345(20):1465–1472
   PubMed Web of Science ®Google Scholar
• . Hoeper MM, Barberà JA, Channick RN, . Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54( 1 suppl):S85–S96
   PubMed Web of Science ®Google Scholar
• . Lang IM. Chronic thromboembolic pulmonary hypertension—not so rare after all. N Engl J Med. 2004;350(22):2236–2238
   PubMed Web of Science ®Google Scholar
• . Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81(2):151–158
   PubMed Web of Science ®Google Scholar
• . Surie S, Gibson NS, Gerdes VE, . Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res. 2010;125(5):e202–e205
   PubMed Web of Science ®Google Scholar
• . Dentali F, Donadini M, Gianni M, . Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res. 2009;124(3):256–258
   PubMed Web of Science ®Google Scholar
• . Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010;95(6):970–975
   PubMed Web of Science ®Google Scholar
• . Klok FA, Surie S, Kempf T, . A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res. 2011;128(1):21–26
   PubMed Web of Science ®Google Scholar
• . Bonderman D, Wilkens H, Wakounig S, . Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33(2):325–331
   PubMed Web of Science ®Google Scholar
• . Wolf M, Boyer-Neumann C, Parent F, . Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395–399
   PubMed Web of Science ®Google Scholar
• . Wong CL, Szydlo R, Gibbs S, Laffan M. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis. 2010;21(3):201–206
   PubMed Web of Science ®Google Scholar
• . Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods VL Jr. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med. 2006;173(11):1270–1275
   PubMed Web of Science ®Google Scholar
• . Morris TA, Marsh JJ, Chiles PG, . High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 2009;114(9):1929–1936
   PubMed Web of Science ®Google Scholar
• . Miniati M, Fiorillo C, Becatti M, . Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Am J Respir Crit Care Med. 2010;181(9):992–996
   PubMed Web of Science ®Google Scholar
• . Mayer E, Jenkins D, Lindner J, . Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–710
   PubMed Web of Science ®Google Scholar
• . Keogh AM, Mayer E, Benza RL, . Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009;54( 1 suppl):S67–S77
   PubMed Web of Science ®Google Scholar
• . Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J; American College of Chest Physicians. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126( 1 suppl):63S–71S
   PubMed Web of Science ®Google Scholar
• . Archibald CJ, Auger WR, Fedullo PF, . Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160(2):523–528
   PubMed Web of Science ®Google Scholar
• . Lewczuk J, Piszko P, Jagas J, . Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119(3):818–823
   PubMed Web of Science ®Google Scholar
• . Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103(3):685–692
   PubMed Web of Science ®Google Scholar
• . Jais X, D'Armini AM, Jansa P, . Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52(25):2127–2134
   PubMed Web of Science ®Google Scholar
• . Becattini C, Manina G, Busti C, Gennarini S, Agnelli G. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res. 2010;126(1):e51–e56
   PubMed Web of Science ®Google Scholar
• . Reichenberger F, Voswinckel R, Enke B, . Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2007;30(5):922–927
   PubMed Web of Science ®Google Scholar
• . Ghofrani HA, Schermuly RT, Rose F, . Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2003;167(8):1139–1141
   PubMed Web of Science ®Google Scholar
• . Suntharalingam J, Treacy CM, Doughty NJ, . Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008;134(2):229–236
   PubMed Web of Science ®Google Scholar
• . Skoro-Sajer N, Bonderman D, Wiesbauer F, . Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2007;5(3):483–489
   PubMed Web of Science ®Google Scholar
• . Nagaya N, Shimizu Y, Satoh T, . Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart. 2002;87(4):340–345
   PubMed Web of Science ®Google Scholar
• . Nagaya N, Sasaki N, Ando M, . Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003;123(2):338–343
   PubMed Web of Science ®Google Scholar
• . Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg. 2005;28(6):882–888
   PubMed Web of Science ®Google Scholar
• . Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg. 2003;76(3):711–718
   PubMed Web of Science ®Google Scholar
• . Simonneau G, Azarian R, Brenot F, Dartevelle PG, Musset D, Duroux P. Surgical management of unresolved pulmonary embolism. A personal series of 72 patients. Chest. 1995;107( 1 suppl):52S–55S
   PubMed Web of Science ®Google Scholar
• . Orens JB, Estenne M, Arcasoy S, . International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25(7):745–755
   PubMed Web of Science ®Google Scholar